Marcos Thompson

Efficacy of Nitazoxanide in reducing the viral load in COVID-19 patients. Randomized, placebo-controlled, single-blinded, parallel group, pilot study.

Marcelo Silva, Andrés Espejo, M.L. González Pereyra et al. · 2021 · 28 citations · Full text

Viral Load, Emerging Infectious Diseases, Disease Severity +15

LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study

Federico Piñero, Marcos Thompson, Federico Díaz Telli et al. · Annals of Hepatology · 2020 · 14 citations · Full text

Failure in all steps of hepatocellular carcinoma surveillance process is frequent in daily practice

Melisa Dirchwolf, Sebastián Marciano, Andrés E. Ruf et al. · Annals of Hepatology · 2021 · 13 citations · Full text

Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis

Oana Nicoară-Farcău, Juan José Lozano, Cristina Alonso et al. · Hepatology · 2023 · 11 citations